Skip to main content

The Aesthetic Society and The Aesthetic Foundation Year in Review 2024

Video

Catch up on the exciting Aesthetic Society and Aesthetic Foundation accomplishments and advances that took place in 2024.

Related Articles

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
In this update, Dr. Pfeifer recaps key highlights from The Aesthetic MEET in Austin, shares insights from attending APS Korea, issues an important cybersecurity warning for plastic surgeons, and previews the upcoming Aesthetic Interactive: Facial & Rhinoplasty Symposium in Boca Raton, Florida.